Test Price
130 AED✅ Home Collection Available
Immunohistochemistry (IHC) Single Marker – Dubai UAE | 130 AED | DHA-Licensed Premium Oncology Diagnostic
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 Accredited Processing.
- Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – your FFPE block or slides are handled with chain-of-custody. Mobile home phlebotomy is disabled for this archival tissue test.
- Clinical Guidance: Telephonic post-test discussion with a DHA-licensed Specialist Diagnostic Radiologist to correlate the IHC result with your histopathology report.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Immunohistochemistry (IHC) Single Marker test detects one protein biomarker on formalin-fixed paraffin-embedded (FFPE) tumor tissue. This quantitative analysis, performed without pathologist interpretation, delivers a high‑specificity signal for cancer subtyping, prognosis, and targeted therapy selection. Results are available in 5–7 days.
| Feature | Our IHC Single Marker | Closest Alternative (Full Interpretation) |
|---|---|---|
| Methodology | Polymer-based IHC, DAB detection | IHC + manual pathologist scoring |
| Precision | 99.9% sensitivity, automated QC | Variable inter‑observer variability |
| Turnaround Time | 5–7 days (block / slides / complex) | 10–14 days |
| Price (AED) | 130 | ≥450 |
| Interpretation | Quantitative result only | Full interpretive report |
| Ideal For | Patients with existing pathology report needing confirmatory biomarker | Complex cases requiring expert synthesis |
Physician Insight & Safety Protocols
“When a single biomarker result can guide targeted therapy, accuracy is paramount. This IHC test provides an objective, machine‑readable protein expression level on your tumor tissue. I review each report alongside your clinical history to ensure the result is correctly correlated with your overall care plan. My goal is to deliver a precise, actionable data point without unnecessary delay.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
⚠️ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. IHC results should always be interpreted alongside the full clinical context and never used independently to alter therapy.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inadequate or necrotic tumor tissue, decalcified specimens, or samples submitted without a copy of the original histopathology report.
- Exclusion: Biopsy site not clearly identified; specimens not submitted as FFPE block or in 10% formal‑saline.
- Exclusion: Pediatric patients without guardian consent compliant with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Red Flag: If the IHC marker result suggests high‑risk overexpression (e.g., HER2 3+ without concurrent FISH), immediate oncologist consultation is mandatory.
- Red Flag: Unexpected loss of critical biomarker (e.g., ER/PR negative in a previously positive case) – do not alter therapy without repeat biopsy.
Patient FAQ & Clinical Guidance
1. What exactly does an IHC single marker test measure, and why do I need it if I already have a pathology report?
An IHC single marker test quantitatively detects a specific protein on your tumor cells, confirming the biomarker status reported in your pathology report. This objective readout helps your oncologist select targeted therapy or predict prognosis without relying solely on subjective interpretation.
2. How is the sample collected and what should I do before the test?
Your existing tumor tissue (biopsy or surgical specimen) must be submitted as a formalin-fixed paraffin-embedded (FFPE) block or in 10% formal‑saline; no new blood draw is needed. Please provide a copy of your original histopathology report, the exact biopsy site, and a brief clinical history. No fasting or medication changes are required.
3. What does the result mean and when will I get it?
The result is reported semi‑quantitatively (e.g., 0 to 3+) along with staining intensity, indicating whether the targeted protein is present. It does not provide a diagnosis or treatment recommendation on its own. Results are issued within 5 days for small biopsies and within 7 days for large complex resections. Your oncologist will then discuss the clinical implications.
UAE Regulatory & Data Privacy Adherence
- Data Protection: All patient information is handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Data Security: Our infrastructure meets the requirements of Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Laboratory Accreditation: Our facility is ISO 15189 accredited and licensed by the Dubai Health Authority (DHA).
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry (IHC) Single Marker |
| Price (AED) | 130 AED |
| Turnaround Time | 5–7 business days |
| Sample Type / Matrix | FFPE tumor tissue block or slides (archival specimen) |
| Methodology Used | Polymer-based IHC with DAB detection |
| ICD-10-CM Code | Z85.9 |
| LOINC Code | 18415-9 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians